Total Funding
60
69
Total FundingSeries B raised
Growth Score 60 in past quarter
-3 pts
Heat Score 69 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
115631
ImmunAbs specialize in antibody therapeutics in global standard development.
About the Company
ImmunAbs specialize in antibody therapeutics in global standard development. The company develops antibody therapeutics for orphan diseases, diabetic retinopathy, and diabetes based on its experience developing antibody therapeutics that have been globally approved for sale in the United States and Europe.